Sophisticated IP counsel without the large-firm overhead.
HYMAN IP LAW provided patent services, licensing assistance, strategic counseling, and intellectual property portfolio reviews with skills honed as a partner at a national firm, but without the national firm overhead.
Laurence J. (Larry) Hyman focused his practice on biotechnology patenting, strategic planning and counseling, technology licensing, intellectual property due diligence, patent portfolio evaluations, and portfolio management. He also advised clients on compliance with reporting requirements for research conducted under federal funding.
Mr. Hyman represented a wide variety of clients, including the U.S. Government, universities and research institutes, start-up and medium-sized biotechnology companies, venture capital groups, and pharmaceutical companies.
Before founding HYMAN IP LAW, Mr. Hyman was a partner at Townsend and Townsend and Crew LLP (now Kilpatrick Townsend & Stockton LLP). Prior to entering private practice, he served in the National Institutes of Health's Office of Technology Transfer as lead patent advisor for the General Medicine Workgroup.
For more than a decade, Mr. Hyman served as a reviewer of grant applications on therapeutics, diagnostics, and medical devices for the UCSF Clinical and Translational Science Institute (CTSI), and as a reviewer of applicants to the California Life Sciences Association's "FAST" Advisory Program for start-ups.
Mr. Hyman's patent and licensing work spanned the full breadth of the life sciences. A number of patents and applications he wrote on inventions by universities and research institutions were licensed by pharma companies and supported substantial investments in clinical development.
Some states may consider this website to be attorney advertising.
HYMAN IP LAW is now closed. Mr. Hyman has retired and is no longer accepting new clients or providing patent or other legal services.